IL18 and gastric cancer: Thus, by selectively upregulating IL-18 but suppressing IL-1β, H. pylori LPS not only inhibits the immune inflammatory response but also promotes gastric cancer cells’ escape from immune surveillance, which facilitates gastric cancer initiation and progression.